| 
      
        | Diseases | Model | Type NKT    cells | Implicated    Mechanism | References |  
        | Diabetes | NOD | I | IL-4,    IL-10 production Inhibition    development pathogenic T cells Selective    recruitment of tolerogenic DC | [44,100] [40] [43] |  
        | Multiple    sclerosis  | EAE | I | IL-4,    IL-10 production Reduced    INF-γ production | [26,101,102] [48,101-103] |  
        | Myasthenia    gravis | EAMG | I | Reduced    INF-γ  Reduced    Acetylcholine-specific antibody
 CD4+, CD25+    regulatory T cells
 | [62] [63] |  
        | Rheumatoid    arthritis | CIA CD1d- and Jα18-knockout mice | I I | Induction    of IL-4 and IL-10 expressionProduction    of IL-4 and IFN- γ
 | [75,76,78,104] |  
        | Allergic    Asthma | OVA    challenged Jα18-/- miceMice    treated with
 DPPE-PEG
 | I I | IL-13,    IL-4 production; Production    of IFN-γ;Production    of IL-4
 | [68] [70,105] |  |